The alkaloid, berberine is widely distributed in the vegetable kingdom. The ber berine containing plants are largely used in indigenous medicine. A crude extract known as "Rasaut, Rasvanti and Rasanjana" is a widely used household remedy as a stomachic, bitter tonic and diaphoretic. There is a renewed interest in berberine because of its reported usefulness in diarrhoeas (1) cholera (2) and experimental amoebiasis (3, 4). Some of our studies on the actions of berberine on the central nervous system are pre sented in this paper.
ing time noted. Significance of results was calculated from duration of sleeping time using student `t' test.
One additional group of 10 mice was administered pentobarbitone (35 mg/kg i.p.) and those animals who lost righting reflex separated. When these mice regained the righting reflex, berberine (5 mg/kg i.p.) was injected to note whether animals again lost their righting reflex.
Amphetamine toxicity: Effect of berberine (5 mg/kg i.p.) on aggregate amphetamine (15 mg/kg i.p.) toxicity was studied in group of 10 male mice at room temperature of 25°C (6) . Chlorpromazine (1 mg/kg i.p.) served as reference compound. Berberine or chlorpromazine was injected 30 minutes prior to amphetamine. The dead mice were removed from time to time and the total number of mice who survived in each group was noted at end of 20 hours.
The experiment was repeated in 2 groups of 10 mice kept singly in cages. One group was treated with amphetamine (100 mg/kg i.p.) and the other was pretreated with berberine 5 mg/kg i.p. Leptazol seizures: 3 groups of 10 mice each were administered leptazol in doses of 20, 50 and 75 mg/kg i.p. respectively. The effect of berberine (5 mg/kg i.p.) on lepta zol induced convulsions was studied in 3 other groups of 10 mice each, berberine being injected 30 minutes prior to leptazol. Criteria for convulsions was clonic convulsions for at least 10 seconds. Supramaximal electroshock convulsions; Male mice, weighing 25 g, were administered a shock of 120 mA for 0.2 seconds through a pair of ear electrodes and only those who responded (tonic hind limb extension) were selected. Selection was done 48 hours prior to the actual experiment. The animals were allowed free access to food and water ex cept during the actual experiment. The effect of berberine (5 mg/kg i.p.) on the supra maximal electroshock convulsions was studied in 10 mice. Ability to abolish the hind limb tonic extensor component of the maximal seizure pattern was taken as an index of anticonvulsant action of the drug. 10 mice treated with phenobarbital sodium (20 mg/kg i.p.) served as control.
Pain threshold: Effect of berberine (5 mg/kg i.p.) on pain threshold in untreated rats and rats treated with morphine (5 mg/kg i.p.) or pentobarbitone (15 mg/kg i.p.) was studied using the hot wire test as described by Gupta and Kulkarni (7). The experi ment was performed in groups of 10 rats, each rat serving as its own control. Interval in between experiments was 8 days. Berberine was injected 30 minutes prior to mor phine or pentobarbitone. Significance of results was calculated using the paired `t' test.
RESULTS

Effects in Cats
Berberine when administered by intraperitoneal route at all 3 dose levels studied namely 5, 20 and 40 mg/kg produced the following effects which commenced in 3-5 minutes-sedation, retching, urination and defaecation with straining. These effects which were seen in 8 cats lasted for less than 2 hours. One cat which was administered berberine in a dose of 5 mg/kg showed a rage reaction which commenced 3 minutes after the injection and was most severe after 13 minutes. The cat returned to normal after an hour. All the 3 cats who were administered berberine by the intraventricular route showed similar effects. The cats were sedated, inactive, disinterested and did not consume food. Effects attributable to peripheral cholinergic stimulation were conspicious by their ab sence. The effects appear to be dose dependant, being more intense in the cats who received 1 mg as compared to the one with 100 ,cg. Moreover, effects commenced im mediately and lasted for 36 to 40 hours in the cats who were treated with 1 mg. With 100 ,eg berberine, effects commenced in 21 minutes and the cat recovered after 20 hours.
Effects in conscious mice
The spontaneous motor activity of white mice recorded in the modified jiggle cage is shown in Fig. 1 . Administration of amphetamine (4 mg/kg i.p.) markedly increased the motor activity, this effect being maximum after 20 minutes. Administration of berberine (5 mg/kg i.p.) at peak activity of amphetamine, sedated the mice in 5 minutes, motor activity being reduced to even below the control level. Pentobarbitone sleeping time Table 1 shows the sleeping time of pentobarbitone before and after berberine (5 mg/kg i.p.). Though berberine potentiated the sleeping time at all 4 dose levels, statis tically significant differences were obtained only at the higher dose levels of pentobarbi tone, namely 35 and 40 mg/kg. It is interesting to note that in the control animals, the sleeping time has not increased with increasing doses of pentobarbitone, although there is an increase in the number of animals losing righting reflex. However, in the animals pretreated with berberine, there is both an increase in sleeping time as well as in number of animals losing righting reflex with increasing dose of pentobarbitone.
Of the group of 10 mice who received 35 mg/kg i.p. of pentobarbitone, 6 lost the righting reflex. These animals on regaining the righting reflex received berberine 5 mg/kg i.p. The animals lost the righting reflex again within a minute and did not re gain it for 43 minutes (average S.E.±9 minutes). Amphetamine toxicity Berberine in a dose of 5 mg ,/kg i.p. did not modify aggregate amphetamine (15 mg/kg i.p.) toxicity, the number of animals surviving in the control as well as berberine treated group being 10%. In contrast, chlorpromazine (1 mg/kg) conferred protec tion to 70% of the mice.
Berberine also did not significantly alter segregate amphetamine toxicity. The percentage of animals who survived in berberine (5 mg/kg i.p.) treated group was 20% as against 30% survival in group treated with amphetamine (100 mg/kg i.p.).
Berberine on convulsions
Berberine (5 mg/kg i.p.) did not have any action on the convulsions produced by leptazol. The percentage of animals who showed convulsions at dose levels of 20, 50 and 75 mg/kg i.p. of leptazol was 10%, 70% and 90% respectively. The response was unaltered with berberine pretreatment.
Berberine (5 mg/kg i.p.) did not protect mice from supramaximal electroshock con vulsions. Thus, all the 10 mice in berberine treated group exhibited convulsions. In contrast, phenobarbitone sodium (20 mg/kg i.p.) offered protection to 50% of the mice.
Pain threshold: (Table 2) Berberine (5 mg/kg i.p.) did not produce any effect on pain threshold in rats , when As expected, pentobarbitone in a sub-hypnotic dose (15 mg/kg i.p.) produced hy peralgesia both at the end of 10 minutes and 45 minutes. Thus, barbiturate treated animals showed a significantly lowered threshold to pain (p<0.01). Berberine (5 mg/ kg i.p.) pretreatment did not modify barbiturate hyperalgesia.
DISCUSSION
Berberine potentiated the hypnotic action of pentobarbitone and this potentiation was significant at the higher dose levels of the barbiturate.
The potentiation of hyp nosis could be due to one of the following factors (1). Berberine itself is a depressant of the central nervous system. Hence potentiation of hypnosis is due to an additive ef fect (2) . The liver microsomal enzymes might be inhibited by berberine, thereby pre venting the destruction of the barbiturate and increasing its blood level (3) . Berberine might facilitate penetration of barbiturate into the brain by altering the blood brain barrier.
Our studies in conscious cats and mice administered berberine by intraperitoneal route, and also our data in conscious cats treated with berberine by intraventricular route has shown that berberine is a sedative. The potentiation of barbiturate hypnosis may therefore be an additive effect.
In the present work, there is no direct evidence of berberine effect on liver micro somal enzyme system. However, there is indirect evidence to suggest that barbiturate potentiation by berberine is a true rather than false potentiation. Jacobsen (8) has stated that addition of a true potentiator increases the percentage of anaesthetized mice, whereas an enzyme inhibitor has no such effect. Also, Fouts and Brodie (9) have put forward the view that a true potentiator will re-induce sleep if administered during a wakening. Both criteria are fulfilled by berberine, which therefore appears to be true potentiator.
Aggregate amphetamine toxicity studies suggest that berberine is not a tranquillizer. It is not surprising that berberine, a sedative did not protect mice treated with ampheta mine and kept singly in cages. Besides chlorpromazine, even potent hypnotics like pentobarbitone and phenobarbitone are known to be ineffective in altering the LD50 of individual mice (10).
Oreshkov (11) reported remissions of spontaneous pain and tenderness in patients with chronic diseases of bile passages, after treatment with berberine. Our studies indi cate that berberine has no analgesic action. In fact, berberine administration has actually reduced the reaction time, though the reduction is not of statistical significance.
The reported effectiveness of berberine may therefore be attributed to some other com ponent like its anti-inflammatory action.
The hyperalgesic action of barbiturates in mice has been reported by Neal (12) .
